Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| enVVeno Medical CorpNVNO · Entity 8104 | Director | September 11, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
enVVeno Medical Corp
Report date September 11, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,351 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Sale · Disposed 11 · Balance 2,351 F1: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 14, 2026 22:56 UTC | enVVeno Medical Corp NVNO · Entity 8104 | SaleCommon Stock | 11 | $11.21 | $123.31 |
DisclosureSEC source: 0001493152-26-042629 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,351 F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 20:05 UTC | enVVeno Medical Corp NVNO · Entity 8104 | SaleCommon Stock | 140 | $10.31 | $1,442.70 |
DisclosureSEC source: 0001493152-26-028426 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,362 F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:05 UTC | enVVeno Medical Corp NVNO · Entity 8104 | SaleCommon Stock | 140 | $11.52 | $1,613.14 |
DisclosureSEC source: 0001493152-26-010047 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,502 F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025. F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $11.5200 to $11.5450, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:40 UTC | enVVeno Medical Corp NVNO · Entity 8104 | SaleCommon Stock | 4,900 | $0.36 | $1,742.44 |
DisclosureSEC source: 0001493152-25-027510 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,544 F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025. F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $0.3554 to $0.3573, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 02:34 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 135,883 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001493152-25-027848 · ownership.xml · derivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,883 Underlying: Common Stock · 135,883 shares Expires 2035-12-11 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 13:00 UTC | enVVeno Medical Corp NVNO · Entity 8104 | SaleCommon Stock | 4,900 | $0.83 | $4,067.00 |
DisclosureSEC source: 0001493152-25-013837 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 97,444 F1 · kind: This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025. F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $0.8205 to $0.84, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 12:00 UTC | enVVeno Medical Corp NVNO · Entity 8104 | PurchaseCommon Stock | 81,433 | $3.07 | $249,999.31 |
DisclosureSEC source: 0001493152-25-000160 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,344 Read SEC document |
| December 18, 2024 Filed Dec 21, 2024 01:33 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 19,752 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001493152-24-051142 · ownership.xml · derivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,752 Underlying: Common Stock · 19,752 shares Expires 2034-12-18 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year. Read SEC document |
| December 05, 2023 Filed Dec 7, 2023 22:05 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 13,856 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001493152-23-044056 · ownership.xml · derivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,856 Underlying: Common Stock · 13,856 shares Expires 2033-12-05 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:30 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 8,403 | $0.00 Strike: $6.70 | $0.00 |
DisclosureSEC source: 0001493152-22-034316 · ownership.xml · derivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,403 Underlying: Common Stock · 8,403 shares Expires 2032-11-30 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:05 UTC | enVVeno Medical Corp NVNO · Entity 8104 | PurchaseCommon Stock | 7,751 | $6.14 | $47,591.14 |
DisclosureSEC source: 0001493152-22-023461 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,911 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:05 UTC | enVVeno Medical Corp NVNO · Entity 8104 | GrantStock Options · Derivative | 7,211 | $0.00 Strike: $6.70 | $0.00 |
DisclosureSEC source: 0001493152-21-030304 · ownership.xml · derivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,211 Underlying: Common Stock · 7,211 shares Expires 2031-11-30 F1 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year. Read SEC document |
| May 17, 2021 Filed May 20, 2021 00:18 UTC | enVVeno Medical Corp HJLI · Entity 8104 | PurchaseCommon Stock, $$0.00001 par value | 9,492 | $5.33 | $50,592.36 |
DisclosureSEC source: 0001493152-21-012296 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,160 F1 · shares: The reporting person acquired these shares of common stock on the open market. Read SEC document |
| February 18, 2021 Filed Feb 23, 2021 02:59 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantStock Option · Derivative | 5,673 | $0.00 Strike: $8.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004537 · ownership.xml · derivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,673 Underlying: Common Stock · 5,673 shares Expires 2031-02-18 F1 · security: The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). F2 · derivative.exercise_date: The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year. Read SEC document |
| July 18, 2020 Filed Jul 22, 2020 01:56 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001493152-20-013753 · ownership.xml · derivative · entry 2 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-18 F1 · security: Granted as part of the annual board compensation package for 2020. F2 · derivative.exercise_date: The common stock options were issued to the Reporting Person on July 18, 2020. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the calendar year. Any non-exercisable portion of the Option will immediately vest and become exercisable in the event that the grantees employment is terminated other than Cause (as defined in the "Employment Agreement") within 3 years of Change of Control as defined in the Plan. Read SEC document |
| July 18, 2020 Filed Jul 22, 2020 01:56 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-013753 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,228 F1 · security: Granted as part of the annual board compensation package for 2020. Read SEC document |
| November 27, 2018 Filed Dec 4, 2018 22:05 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantStock Options · Derivative | 60,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001493152-18-017034 · ownership.xml · derivative · entry 2 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2021-10-02 F3 · security: The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018. F3 · derivative.exercise_date: The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018. Read SEC document |
| November 27, 2018 Filed Dec 4, 2018 22:05 UTC | enVVeno Medical Corp HJLI · Entity 8104 | GrantRestricted Stock units | 29,183 | $2.57 | $75,000.31 |
DisclosureSEC source: 0001493152-18-017034 · ownership.xml · nonDerivative · entry 1 Duhay Francis · CIK 0001760582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,183 F1 · security: The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"),, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021. F2 · security: Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. F1 · kind: The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"),, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.